Press release
AmeraCell Bio Hacking with Wharton's Jelly IV Therapy
Fairfax Virginia - AmeraCell, [https://ameracell.com/]a leading provider of regenerative medicine solutions, is proud to announce the launch of its innovative Wharton's Jelly IV therapy. This groundbreaking treatment harnesses the power of mesenchymal stem cells (MSCs), cellular solutions, and exosomes to promote overall wellness and address various health conditions.
About Wharton's Jelly IV Therapy
Wharton's Jelly, a gelatinous substance extracted from umbilical cords, is rich in MSCs, growth factors, and other beneficial compounds. AmeraCell's proprietary IV therapy utilizes this potent mixture to deliver a concentrated dose of regenerative cells and signals directly into the bloodstream.
"As Chief Medical Officer at AmeraCell, I am thrilled to introduce our innovative matrix of micro a nano particles in our IV therapy to the medical community. This groundbreaking treatment has the potential to revolutionize the way we approach regenerative medicine, and I am eager to see the positive impact it will have on our patients' lives." - Dr. Naveen Doki
Benefits of Wharton's Jelly IV Therapy
- Enhances overall wellness and vitality
- Supports tissue repair and regeneration
- May improve symptoms of chronic conditions, such as arthritis and autoimmune disorders
- Boosts immune system function
What Sets AmeraCell Apart
AmeraCell's commitment to quality, safety, and innovation has earned it a reputation as a leader in the regenerative medicine field. Our Wharton's Jelly IV therapy is:
- Derived from ethically sourced, screened, and tested umbilical cords
- Processed in a state-of-the-art, FDA-registered facility
- Administered by experienced healthcare professionals in a clinical setting
About AmeraCell
AmeraCell is a pioneering regenerative medicine company dedicated to providing cutting-edge therapies that improve human health and quality of life. Our mission is to empower individuals to take control of their wellness journey through innovative, safe, and effective treatments.
Contact Information
To learn more about AmeraCell's Wharton's Jelly IV therapy or to schedule a consultation, please visit our website at AmeraCell.com or contact us directly:
Phone: 407 801 2269
Email: AmeraCellClinics@Gmail.com
Note to editors:
For high-resolution images, interview requests, or additional information, please contact AmeraCell [https://ameracell.com/] at AmeracellClinics@gmail.com [mailto:AmeracellClinics@gmail.com].
Media Contact
Company Name: AmeraCell
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=ameracell-bio-hacking-with-whartons-jelly-iv-therapy]
Address:300 N Atlantic Ave #108
City: Cocoa Beach
State: FL 32931
Country: United States
Website: https://ameracell.com/pharmacy
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AmeraCell Bio Hacking with Wharton's Jelly IV Therapy here
News-ID: 3826043 • Views: …
More Releases from ABNewswire
Ilana McBain Launches Limited Edition Fine Art Print Series as Her Profile Rises …
Sunshine Coast artist Ilana McBain has launched a new series of Limited Edition Fine Art Prints featuring 20 variations, each capped at only 100 editions worldwide. Hand-signed, individually numbered, and produced on museum-grade archival paper, the collection reflects McBain's rising profile and growing international collector base. The series showcases her bold, contemporary style and is available now through her online shop.
SUNSHINE COAST, QLD - Australian multidisciplinary artist Ilana McBain today…
Dualentry Explains Why AI Won't Replace Accountants but Will Transform Accountin …
Ask CFOs if artificial intelligence will eliminate their departments, and you'll trigger an immediate defensive reaction.
Of course not; someone needs to ensure compliance, interpret complex standards, make judgment calls. Yet while they're defending their teams, something remarkable is happening: JPMorgan Chase just eliminated 360,000 hours of annual legal document review work with a single AI platform.
PwC announced a $1 billion three-year investment to expand and scale its AI capabilities, including…
Combat Veteran-Physician's MedEq Fitness Empowers Holiday Health Transformations …
MedEq Fitness's complete wellness ecosystem, from hyperbaric chambers to ice plunges, captures holiday market after generating $250,000 in first 90 days. The physician-combat veteran founder's personal long COVID recovery story drives mission to democratize advanced wellness technology.
MedEq Fitness transforms the landscape of home wellness following its remarkable $250,000 revenue generation in just 90 days, as the physician and combat veteran-founded company capitalizes on surging holiday demand for comprehensive health solutions…
Marginal Zone Lymphoma Treatment Pipeline Shows Strong Momentum as 50+ Pharma Co …
DelveInsight's "Marginal Zone Lymphoma Pipeline Insight 2025" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Marginal Zone Lymphoma pipeline landscape. It covers the Marginal Zone Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Marginal Zone Lymphoma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Download DelveInsight's…
More Releases for AmeraCell
AmeraCell Partners with StemWave to Offer Innovative Pain Management Solutions
Image: https://www.abnewswire.com/upload/2025/02/289e8b2e1d891a628fce90b1532c39f3.jpg
Fairfax, VA - AmeraCell, a leading provider of life science medicines, is pleased to announce that it has signed a Letter of Intent (LOI) with StemWave, a pioneering provider of non-invasive pain management solutions.
This strategic partnership aims to provide patients with cutting-edge regenerative medicine solutions for pain management, leveraging the expertise of both organizations.
"We are thrilled to partner with StemWave to offer our patients innovative pain management options," said…
AmeraCell Launches Revolutionary Wharton's Jelly MSc IV Therapy for Advanced Wel …
Image: https://www.abnewswire.com/upload/2025/01/9c6215166ea166a615398ac58e4d78ef.jpg
Fairfax, Virginia - AmeraCell [https://ameracell.com/], a Life Science Clinic, is proud to announce the launch of its groundbreaking Wharton's Jelly MSc IV therapy. This innovative treatment utilizes the regenerative power of Wharton's jelly, cellular solutions, and mesenchymal cells to enhance overall wellness and address various chronic health conditions.
Wharton's Jelly MSc therapy is derived from ethically sourced umbilical cords. It is rich in Wharton's jelly, growth factors, and other bioactive…
AmeraCell Appoints Renowned Oncologist and Hematologist, Naveen Doki, MD, as Chi …
Image: https://lh7-rt.googleusercontent.com/docsz/AD_4nXf6lnWBjHtv1vNESJODCnyAI57Da6r_Bsny_CRL1HkRArIePBqhfHdc8E-3Mgv1srSjvPOZ0kOPN5esunTJVx31kwbLHZ4FGlGNuQxjEUfHP-Zx61Epyfu5917VDsN1YeM0FvdySA?key=pfjRRuJ_S4XBBGPHHK1PXqNz
New York New York - AmeraCell [https://ameracell.com/], a cutting-edge life science company, announced today the appointment of Naveen Doki, MD, as its Chief Medical Officer (CMO). Dr. Doki brings over a decade of experience in oncology and hematology from the DC Metro area to his new role.
As CMO, Dr. Doki will spearhead the development and implementation of AmeraCell's medical strategies, ensuring the company remains at the forefront of regenerative…
AmeraCell Solidifies Leadership in Life Sciences with Plans for Innovation and E …
Image: https://www.abnewswire.com/upload/2025/01/362d0397e292acf147cd220e0ad40f81.jpg
Washington, D.C. - January 2, 2025 - AmeraCell [https://ameracell.com/], a pioneering name in the life sciences sector, is proud to announce its continued success in 2024, solidifying its reputation as an industry leader. With a network of eight strategic locations across the United States, AmeraCell continues to redefine healthcare innovation and deliver exceptional patient outcomes. The company remains dedicated to improving lives through groundbreaking health solutions and personalized care.
Reflecting…
AmeraCell Accessible Affordable Bio Hacking in Katy Texas an American Life Scien …
Image: https://www.abnewswire.com/uploads/c46306625cd5028d1dcf9ba4de05042c.png
Katy, TX - AmeraCell, a pioneering life science company, is thrilled to announce its expansion into Katy, Texas. This strategic move marks a significant milestone in AmeraCell's mission to democratize access to innovative, life-changing therapies.
AmeraCell's Katy location will offer a comprehensive range of life science solutions, including:
- Bio-Hacking: Personalized wellness programs leveraging cutting-edge technology and medical expertise
- Stem Cell Therapy: MSC stem cell joint injections and IV hydration treatments…
AmeraCell Bio Hacking in Katy, Texas with Cutting-Edge Life Science Solutions
Image: https://www.abnewswire.com/uploads/79e38f5d5a8c3789b9f55057ecaf6d44.png
Katy, TX - AmeraCell, a pioneering life science company, is thrilled to announce its expansion into Katy, Texas. This strategic move marks a significant milestone in AmeraCell's mission to democratize access to innovative, life-changing therapies.
AmeraCell's Katy location will offer a comprehensive range of life science solutions, including:
- Bio-Hacking: Personalized wellness programs leveraging cutting-edge technology and medical expertise
- Stem Cell Therapy: MSC stem cell joint injections and IV hydration treatments…
